Data on this page show the responses of parents and carers of individuals aged 6 months to younger than 5 years who received a standard influenza vaccine and completed an AusVaxSafety survey sent in the days following vaccination.

Standard influenza vaccines currently in use in this age group include:

  • Fluarix Tetra®
  • Flucelvax® Quad
  • FluQuadri®
  • Influvac® Tetra
  • Vaxigrip Tetra®.

These data provide a profile of what to expect in the days following your child’s influenza vaccination and can assist in planning for vaccination.

Data on this page will be updated weekly throughout the 2024 influenza season.

AusVaxSafety's active vaccine safety surveillance system complements the enhanced safety surveillance activities of the Therapeutic Goods Administration.

Further information on the influenza vaccines can be found at the links below:

Last updated May 2024